Cargando…
The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
Alopecia areata is a type of non-scarring hair loss. The dysregulation of numerous systemic Th1 (IL-2, IFN-γ, TNF, IL-12, and IL-18), Th2 (IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, IL-17E, IL-31 and IL-33) and Th17 (IL-17, IL-17F, IL-21, IL-22, IL-23 and TGF-β) cytokines was observed in patients with al...
Autores principales: | Waśkiel-Burnat, Anna, Osińska, Marta, Salińska, Anna, Blicharz, Leszek, Goldust, Mohamad, Olszewska, Małgorzata, Rudnicka, Lidia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699846/ https://www.ncbi.nlm.nih.gov/pubmed/34943905 http://dx.doi.org/10.3390/cells10123397 |
Ejemplares similares
-
Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2023) -
Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
por: Papierzewska, Małgorzata, et al.
Publicado: (2023) -
Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
por: Rudnicka, Lidia, et al.
Publicado: (2021) -
Lipocalin-2 and insulin as new biomarkers of alopecia areata
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2022) -
Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2021)